Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan

CONCLUSION: In this study, the addition of adjuvant treatment was associated with an OS benefit for patients with LVSI, especially those with grade 3 endometrioid tumors.PMID:38130137 | DOI:10.3802/jgo.2024.35.e33
Source: Journal of Gynecologic Oncology - Category: OBGYN Authors: Source Type: research